| disease status |
phenotype |
7 |
3 |
|
| disease susceptibility |
phenotype |
9 |
4 |
disease susceptibility, genetic susceptibility to disease |
| disinhibited behaviors |
phenotype |
2 |
2 |
|
| disinhibition |
phenotype |
15 |
11 |
SSS-D, behavioral undercontrol, dis‑inhibition, facets of disinhibition, higher-order construct of disinhibition, personality traits associated with disinhibition, traits-related to disinhibition |
| disinhibitory behavior |
phenotype |
3 |
2 |
|
| disinhibitory behaviors |
phenotype |
2 |
2 |
|
| Disinhibitory disorders |
phenotype |
3 |
3 |
Disinhibitory disorders |
| disorder |
phenotype |
22 |
15 |
biological process disorder, disorder, outcome, psychiatric disease, psychiatric disorder, psychiatric disorders |
| disordered eating |
phenotype |
2 |
2 |
|
| disorganization |
phenotype |
3 |
3 |
disorganized |
| dispase |
drug |
6 |
4 |
dispase (Sigma), dispase digestion |
| distant eQTL |
cohort |
2 |
— |
|
| distractibility |
phenotype |
2 |
1 |
distractability |
| disulfiram |
drug |
11 |
9 |
Antabuse |
| Dithiothreitol |
drug |
2 |
2 |
DTT, dithiothreitol |
| diverse populations |
cohort |
3 |
— |
|
| dizziness |
phenotype |
6 |
4 |
dizziness, dizziness rating, dizzy |
| DKK1 |
gene |
3 |
3 |
Dickkopf-1, Dkk1 |
| d/l AP-5 |
drug |
3 |
3 |
AP-5, D-AP5 |
| Dlg2 |
gene |
2 |
1 |
Dlg2, PSD93 |
